The EFMC Best Poster Prizes have been granted to the following participants :

• P385 - Ben CONS (Astex)
  OPTIMISATION OF ELECTROSTATIC COMPLEMENTARITY IN STRUCTURE-BASED DRUG DISCOVERY
  
  
• P480 - Blake CURTIS (Australian National University)
  EXPLOITING PARASITE CHOLESTEROL METABOLISM FOR DRUG DELIVERY
  
  
• P421 - Evelyne DIETRICH (Repare Therapeutics)
  DISCOVERY OF AN ORALLY BIOAVAILABLE AND SELECTIVE PKMYT1 INHIBITOR RP-6306
  
  
• P289 - Sandra KOVACHKA (Côte d’Azur University)
  PANICEIN A HYDROQUINONE AND ANALOGS OVERCOME CHEMOTHERAPY RESISTANCE IN CANCER CELL
  
  
• P420 - Caroline LANTHIER (UAntwerp)
  RECENT ADVANCES IN THE DEVELOPMENT OF A NEW GENERATION OF UAMC-3203 ANALOGS TO INHIBIT FERROPTOSIS

• P165 - Angela MARTIN SERRANO ORTIZ (University of Grenoble-Alpes)
  PRECLINICAL EVALUATION OF ANTIBODY RECRUITING GLYCODENDRIMERS (ARGs) FOR CANCER THERAPHY
  
  
• P517 - Pilar SUAREZ DE CEPEDA FUENTES (University of Santiago de Compostela)
  MOLECULAR BASIS OF THE ULTRABROAD SPECTRUM OF ACTIVITY OF QPX7728 – A BICYCLIC BORONATE β-LACTAMASE INHIBITOR
  
  
• P448 - Julian WITT (University of Hamburg)
  DEVELOPING ANTITUMORAL TRIPPPRO-COMPOUNDS

The ICBS Best Poster Prizes have been granted to the following participants :

• Poster P442 - Carlo MATERA (University of Milan)
  APPLICATIONS OF MOLECULAR PHOTOSWITCHES IN CHEMICAL BIOLOGY
  
  
• Poster P358 - Doroteja NOVAK (University of Ljubljana)
  BREAKING THE PARADIGM: RADIOLABELLED CCK₂R ANTAGONISTS ARE SUPERIOR TO RADIOLABELLED AGONISTS IN IN VIVO SETTING